Cargando…
Two Possible Strategies for Drug Modification of Gemcitabine and Future Contributions to Personalized Medicine
Drug repurposing is an emerging strategy, which uses already approved drugs for new medical indications. One such drug is gemcitabine, an anticancer drug that only works at high doses since a portion is deactivated in the serum, which causes toxicity. In this review, two methods were discussed that...
Autores principales: | Pereira, Mariana, Vale, Nuno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746447/ https://www.ncbi.nlm.nih.gov/pubmed/35011522 http://dx.doi.org/10.3390/molecules27010291 |
Ejemplares similares
-
Personalized Medicine for Classical Anesthesia Drugs and Cancer Progression
por: Costa, Bárbara, et al.
Publicado: (2022) -
Understanding Lamotrigine’s Role in the CNS and Possible Future Evolution
por: Costa, Bárbara, et al.
Publicado: (2023) -
Evolution of Antiretroviral Drug Rilpivirine and Approach to Oncology
por: Pereira, Mariana, et al.
Publicado: (2023) -
Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy
por: Han, Haijie, et al.
Publicado: (2022) -
Evaluation of synergism in drug combinations and reference models for future orientations in oncology
por: Duarte, Diana, et al.
Publicado: (2022)